Stem cell therapies involve using stem cells, which can develop into various specialized cell types, to treat disease or repair tissue, and they are among the most aggressively marketed longevity treatments sold today. Worth being precise here, blood and bone marrow stem cell transplants for specific blood cancers and certain blood disorders are real, FDA-approved, well-established treatments, a narrow, specific category considerably different from the much larger industry of clinics marketing stem cell injections for joint pain, anti-aging, or general wellness, most of which operate in a largely unregulated space.
- Blood/bone marrow transplants for specific blood cancers are genuinely FDA-approved.
- Clinics marketing joint injections or anti-aging stem cell treatments largely operate unregulated.
- The FDA has issued specific public warnings about this unregulated industry.
- Documented serious complications include infections and, in some cases, blindness.
The unregulated stem cell clinic industry
Alongside the narrow, approved blood-cancer application, a meaningfully larger industry of clinics has emerged marketing stem cell injections for joint pain, sports injuries, and general anti-aging or wellness purposes, most operating without the same FDA approval, rigorous clinical trial evidence, or regulatory oversight backing the approved blood-cancer treatments. This is a genuinely important distinction to understand, the word "stem cell" in a treatment's marketing doesn't automatically mean it carries the same evidence standard as the approved applications, most of these marketed treatments simply haven't been through that same regulatory process.
Documented risks, not hypothetical ones
This isn't a purely theoretical concern, the FDA has issued specific public warnings about this unregulated stem cell clinic industry, documenting real cases of serious complications, including infections and, in some particularly severe reported cases, blindness resulting from unregulated stem cell injections. These are genuine, documented harms, worth taking seriously rather than assuming a treatment marketed at a wellness clinic carries the same safety profile as an approved medical procedure performed under proper clinical oversight.
What is approved, what is marketed, and how to tell them apart
Stem cell medicine contains one of the genuine triumphs of twentieth-century treatment and one of the largest unregulated markets in healthcare. Distinguishing them isn’t difficult once you know what to look at.
The approved use: haematopoietic stem cell transplantation
Bone marrow and blood stem cell transplants have been standard care for decades, used for leukaemia, lymphoma, aplastic anemia and certain inherited immune and metabolic disorders. The mechanism is well understood: the patient's blood-forming system is destroyed and replaced by donor stem cells that reconstitute it.
It works because the cells are being asked to do exactly what they do naturally, in the tissue they belong to. It is also a serious procedure with real mortality risk, used because the alternative is worse.
Other legitimate categories
A small number of additional products have regulatory approval in specific jurisdictions, including limb-derived corneal epithelial treatments for eye burns and some cord blood products. Each is narrow, tissue-specific and supported by trial data.
What clinics actually sell
The large commercial market centers on injections of mesenchymal stromal cells, usually from fat or bone marrow, for osteoarthritis, back pain, sports injuries, neurological conditions and general anti-aging. None of these has FDA approval in the United States.
A terminology point worth knowing: mesenchymal cells from fat aren’t truly stem cells in the strict sense, and the field increasingly calls them stromal rather than stem cells. Clinics haven’t followed suit, because the word carries the credibility.
Documented harms
- Vision loss. Multiple patients suffered severe permanent vision loss after intravitreal injections of fat-derived cells at a Florida clinic, in a case reported in the New England Journal of Medicine.
- Tumours. Case reports document tumour formation following stem cell treatment, including a spinal mass after treatment abroad.
- Infections. Bacterial infections including bloodstream infections have been traced to contaminated umbilical cord blood products.
How to evaluate any offer
Ask three questions. Is the treatment approved by a recognized regulator for this specific condition? Is it being provided within a registered clinical trial with ethics approval and no charge for the experimental intervention? Are the results published in peer-reviewed literature rather than testimonials? Legitimate research answers yes; the commercial market generally answers no to all three while charging heavily. Kuriyan and colleagues reported it in the New England Journal of Medicine: three patients paid a commercial clinic for intravitreal injection of their own cells, marketed as treatment for macular degeneration, and were left with severe permanent vision loss. The cells were autologous, which removes the most common reassurance clinics offer. Your own cells does not make a procedure safe.
Approved use vs. marketed use
| Blood/Bone Marrow Transplant | Clinic-Marketed Injections (Joint, Anti-Aging) | |
|---|---|---|
| FDA approval | Yes, for specific blood conditions | Generally no |
| Regulatory oversight | Rigorous | Largely absent |
| Documented safety record | Well-established | FDA has issued specific warnings |
Approved use against marketed use. The gap between the two columns is what the clinic industry occupies.
Checking what is actually approved
Popular health writing borrows the credibility of approved blood-cancer stem cell treatments to lend weight to unrelated, unregulated clinic offerings. The association is misleading and worth recognising. The check that matters is whether the product has marketing authorisation for the indication being offered. Not whether the clinic is licensed, and not whether the doctor is qualified. Those are different things, and clinics often substitute them.
If a stem cell treatment is being marketed for joint pain, anti-aging or general wellness, verify its regulatory approval for that specific use before anything else. Approved for one indication doesn’t mean approved for yours.
The documented harms from the unregulated side of this industry are real, not hypothetical. That is the reason the distinction matters rather than a technicality.
The app is honest about this approved-vs-marketed distinction, not conflated.
Sources
Key references for the claims on this page. Where a figure is attributed to a specific study or body, it is named here.
- The regulatory claims on this page — what is approved, for which indications, and what enforcement action has been taken against unapproved clinics — are not separately cited. Haematopoietic stem cell transplantation for specific blood and immune conditions is the established approved use, and it is quite different from what clinics market.
- Kuriyan AE, Albini TA, Townsend JH, et al. Vision Loss after Intravitreal Injection of Autologous “Stem Cells” for AMD. New England Journal of Medicine, 2017. The documented vision-loss cases.
Frequently asked
What stem cell therapies are actually FDA-approved?
Blood/bone marrow transplants for specific blood cancers and disorders, a narrow, specific category.
Are joint injection or anti-aging clinics regulated the same way?
No, most operate in a largely unregulated space without the same approval or oversight.
What are the risks of unregulated treatments?
The FDA has documented serious complications including infections and, in some cases, blindness.
Are stem cell injections for knees FDA-approved?
No. Stem cell injections for osteoarthritis and joint pain aren’t approved treatments in the United States, despite being widely advertised. Clinics offering them are operating in a space the regulator has repeatedly said falls outside approval.
What are stem cells actually approved for?
Hematopoietic stem cell transplantation for certain blood cancers and blood disorders is well established and genuinely transformative. That is the approved use, and it looks nothing like the anti-aging treatments being marketed.
Is stem cell tourism dangerous?
Documented harms from unregulated clinics include serious infections, tumour formation and, in several widely reported cases, blindness following eye injections. These are recorded outcomes rather than theoretical concerns.
What are exosomes?
Small vesicles released by cells, marketed alongside stem cell treatments as a related product. The FDA has issued warnings about unapproved exosome products, including after reports of serious adverse events.
Do stem cells reverse aging?
There is no human evidence supporting this. The idea borrows credibility from the genuine successes of transplantation medicine, which addresses a completely different problem in a completely different way.